Name: 2nd Annual MarketsandMarkets Single Cell-Omics Conference
Start: 2023-10-09
End: 2023-10-10
Location: Ibis London Earls Court Hotel & ILEC Conference Centre

WHAT TO EXPECT

Single cell genomic analysis for cancer/cellular heterogeneity
Single Cell Transcriptional Profiling, Digital spatial profiling
Spatial Single cell genome analysis – Sequencing application
Single-Cell phenotyping
Application of multiplex imaging – Single cell and tissue imaging
Current & Emerging Tools and Data Analysis in Single Cell Omics
Single Cell Analysis in Drug Discovery & Development – Sample Preparation and Processing

Industry: Pharma/Therapeutic Companies/Start Up’s
CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Geneticists, Bioinformatician, Protein Scientist, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders
Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data Science, Microbiologists, Virologists, Pathologists
Academics: Universities, Research Institutes, Hospitals
Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data science, Microbiologists, Virologists, Pathologists

Witness live action how Single-Cell Omics technology is revolutionizing the future of Biomedical research
Quality insights and cohesiveness of key issues with respect to Single-Cell to be addressed
Discover the different avenues in application of Multi-Omics studies
Comprehend the current and future research avenues of Single-Cell Omics in drug discovery and development
Discuss the emerging technologies and opportunities with cutting edge strategies
Opportunity for one-on-one networking with the delegates and extend professional competency

CONFERENCE AGENDA

Registration	09:00 - 09:25
Opening remarks by the Chairperson Monica Raimo, Senior Research Manager and Team Lead, Glycostem Therapeutics	09:25 - 09:30
Novel Research in Single-Cell Omics Analysis
Spatial Genomics - Understanding Issues the Hard Way Nik Matthews, Head of the Imperial BRC Genomics Facility, Imperial College London	09:30 - 10:00
Current Landscape of Liquid Biopsies as a Tool for Cancer Diagnosis and Prognosis Emmanouil Karteris, Reader in Biomedical Sciences, Brunel University	10:00 - 10:30
Namocell, Low Pressure Single Cell Dispensing to Improve Cell Viability Steven Johnstone, Field Applications Scientist, EMEA FAS, Bio-Techne	10:30 - 11:00
Morning Refreshments \| One-to-One Networking Meeting	11:00 - 11:40
Protein Quantification from a Single Cell Using TMTpro™ Mass Spectrometry Illip Burmester, Technical and Applications Manager, Proteome Sciences	11:40 - 12:10
Deconvoluting Genetic and Transcriptomic Tumour Heterogeneity Underlying Aggressive ER+ Breast Cancers. Shefali Thakur, Higher Scientific Officer, The Institute of Cancer Research	12:10 - 12:40
WOLF Microfluidic Sorting Preserves Cell Health, Stemness and Viability Michal Bonar, Distribution Support Manager EMEA, Nanocellect	12:40 - 13:10
Digital spatial profiling Leveraging Multiomics Data to better understand Mechanisms of Resistance to Therapy and Develop Cancer Biomarkers. Danish Memon, Lead Bioinformatics Scientist, ThirtyFiveBio	13:10 - 13:40
Lunch and Poster Presentation \| One-to-One Networking	13:40 - 14:40
Single-Cell Sequencing in Rare Diseases and our Research is now more focusing on Therapeutics of Rare Diseases: Using Autologous Stem Cell Therapy in the Area of Muscle Diseases, Cancer, and Aging Related Diseases. Rick Kamps, Head Research Engineer in the Department of Toxicogenomics, Maastricht University	14:40 - 15:15
Panel Discussion – ‘’Targeting Tumour Microenvironment for Clinical Outcomes – How far are we?’’ Shefali Thakur, Higher Scientific Officer, The Institute of Cancer Research Emmanouil Karteris, Reader in Biomedical Sciences, Brunel University Dimitrios A. Lamprou, Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast Danish Memon, Lead Bioinformatics Scientist, ThirtyFiveBio Moritz Haneklaus, Senior Research Scientist, Macomics	15:15 - 16:00
Evening Refreshments and Poster Presentation \| One-to-One Networking	16:00 - 16:40
Using Omics to Advance Macrophage Drug Discovery Moritz Haneklaus, Senior Research Scientist, Macomics	16:40 - 17:15
Closing Remarks from the Chairperson Monica Raimo, Senior Research Manager and Team Lead, Glycostem Therapeutics	17:15 - 17:20
Drinks Reception and Networking	17:20 - 17:20
End of Day 1	17:20 - 17:20

Registration	08:15 - 08:50
Welcome note by MarketsandMarkets	08:50 - 08:55
Opening remarks by the Chairperson Monica Raimo, Senior Research Manager and Team Lead, Glycostem Therapeutics	08:55 - 09:00
Emerging tools and Technologies in Single Cell Omics
Changing Research in Omics Data Alessandro Riccombeni, CEO and founder, Axia Medicine	09:00 - 09:30
Biophysical Approaches for Live Single Cell Analysis Stephen Evans, Professor, University of Leeds	09:30 - 10:00
Microfluidics for continuous and scalable approaches in nanomedicine Dimitrios A. Lamprou, Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking	10:30 - 11:20
Identification of Signatures of Superior Cytotoxic NK Cells via Bulk and Single-Cell Transcriptomics Monica Raimo, Senior Research Manager and Team Lead, Glycostem Therapeutics	11:20 - 11:55
Single-cell Whole Genome Sequencing to study Somatic CNVs in Human Post-Mortem Brains Ester Kalef-Ezra, Postdoctoral Research Fellow, Proukakis Lab, University College London	11:55 - 12:30
How to deal with Single Cell Omics Data in Research, Diagnostics, and Public Health? Rick Kamps, Head Research Engineer in the Department of Toxicogenomics, Maastricht University	12:30 - 13:15
Lunch \| One-to-One Networking	13:15 - 14:15
Single Cell Project Design: Fitting the Single Cell Samples to the Technology Nik Matthews, Head of the Imperial BRC Genomics Facility, Imperial College London	14:15 - 14:45
Closing remarks by the Chairperson Monica Raimo, Senior Research Manager and Team Lead, Glycostem Therapeutics	14:45 - 14:50
End of Conference	14:50 - 14:50